Thanks.
I hold SOM and looked up the reference you suggested on the SOM thread about the Oventus device.
Its a crowded market but addressable market is large.
Oventus device to looks have some advantages for some people.
Traction so far (in terms of sales) has been poor, but maybe too early. Manufacturing margin also seemed a problem, which they are addressing.
I am watching with interest though.
looks to have a big retail following- a share price jump of 15% on news of FDA approval (which was always going to happen and expected) shows a little retail enthusiasm!
- Forums
- ASX - By Stock
- Ann: FDA Clearance for O2Vent Optima Oral Device
Thanks.I hold SOM and looked up the reference you suggested on...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)